DENVER, April 9, 2018 /PRNewswire/ -- Fischer Medical has announced that the Bloom2 cardiac electrophysiology stimulator device has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The Bloom2 stimulator is a fundamental component of nearly all electrophysiology (EP) procedures to diagnose and treat cardiac rhythm disorders.
The release of the digital version of the Bloom gives electrophysiologists and EP staff members a modern user interface, eliminates tedious dropdown menus and retains the tactile feel of the original Bloom. Physicians have long used the original analog Bloom for their patients since it was introduced by Murray Bloom in the 1970s. The Bloom2 was painstakingly engineered with the classic Bloom user in mind, mapping the analog system directly to the digital so the adoption of the digital system would be simple and intuitive for Bloom customers.
"The Bloom2 represents years of research and development to integrate the key components of what made the original Bloom the market leading stimulator worldwide," said Wes Rogers, President & CEO of Fischer Medical. "The Bloom2 is the only stimulator on the market that offers the tactile feel of the original Bloom combined with a state-of-the-art user interface."